JP2023500686A5 - - Google Patents
Info
- Publication number
- JP2023500686A5 JP2023500686A5 JP2022525785A JP2022525785A JP2023500686A5 JP 2023500686 A5 JP2023500686 A5 JP 2023500686A5 JP 2022525785 A JP2022525785 A JP 2022525785A JP 2022525785 A JP2022525785 A JP 2022525785A JP 2023500686 A5 JP2023500686 A5 JP 2023500686A5
- Authority
- JP
- Japan
- Prior art keywords
- preferably less
- multiblock copolymer
- copolymer matrix
- less
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19206786 | 2019-11-01 | ||
| EP19206786.6 | 2019-11-01 | ||
| PCT/NL2020/050674 WO2021086188A1 (en) | 2019-11-01 | 2020-10-30 | Dosage form for extended release of an antibody or large protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500686A JP2023500686A (ja) | 2023-01-10 |
| JP2023500686A5 true JP2023500686A5 (enExample) | 2024-12-19 |
| JP7737983B2 JP7737983B2 (ja) | 2025-09-11 |
Family
ID=68426231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525785A Active JP7737983B2 (ja) | 2019-11-01 | 2020-10-30 | 抗体又は巨大タンパク質の延長された放出の為の剤形物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220409730A1 (enExample) |
| EP (1) | EP4051233A1 (enExample) |
| JP (1) | JP7737983B2 (enExample) |
| WO (1) | WO2021086188A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102024129442A1 (de) | 2024-10-11 | 2026-04-16 | Universität Potsdam, Körperschaft des öffentlichen Rechts | Polymer-gekoppelte antikörper und antikörperfragmente |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999042147A1 (en) | 1998-02-23 | 1999-08-26 | Massachusetts Institute Of Technology | Biodegradable shape memory polymers |
| WO2012005594A2 (en) | 2010-07-09 | 2012-01-12 | Innocore Technologies B.V. | Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| CA2842514C (en) | 2011-07-22 | 2018-12-18 | Innocore Technologies B.V. | Biodegradable, semi-crystalline, phase separated, thermoplastic multi-block copolymers for controlled release of biologically active compounds |
| WO2013157953A1 (en) | 2012-04-20 | 2013-10-24 | Merus B.V. | Methods and means for the production of ig-like molecules |
-
2020
- 2020-10-30 EP EP20801416.7A patent/EP4051233A1/en active Pending
- 2020-10-30 WO PCT/NL2020/050674 patent/WO2021086188A1/en not_active Ceased
- 2020-10-30 US US17/773,520 patent/US20220409730A1/en not_active Abandoned
- 2020-10-30 JP JP2022525785A patent/JP7737983B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017113019A5 (enExample) | ||
| JP2018064580A5 (enExample) | ||
| JP2017079785A5 (enExample) | ||
| JP2016040284A5 (enExample) | ||
| JP2014221758A5 (enExample) | ||
| HRP20200745T1 (hr) | Agensi koji vezuju cd123 i njihove upotrebe | |
| JP2012034692A5 (enExample) | ||
| JP2015532292A5 (enExample) | ||
| JP2013538796A5 (enExample) | ||
| UA116194C2 (uk) | Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном | |
| JP2017512193A5 (enExample) | ||
| JP2014502955A5 (enExample) | ||
| JP2016513640A5 (enExample) | ||
| JP2019031567A5 (enExample) | ||
| PE20241623A1 (es) | Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y usos de los mismos | |
| JP2013502204A5 (enExample) | ||
| JP2011157378A5 (enExample) | ||
| JP2018535961A5 (enExample) | ||
| JP2019509054A5 (enExample) | ||
| CN111542546A (zh) | 抗lag-3 抗体及其用途 | |
| JP2019517504A5 (enExample) | ||
| JP2021504404A5 (enExample) | ||
| JP2012522788A5 (enExample) | ||
| JP2006500344A5 (ja) | 複合遅延放出抗生物質製剤、その使用及びその作成方法 | |
| JP2010527939A5 (enExample) |